Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Letters|July 19, 2020
YB-1: The key to personalised prostate cancer management?Mark Bates, Anna Boland, Niamh McDermott, et al.
Cancer Cell|March 20, 2019
Capitalizing on Cancer Replication Stress by Preventing PAR Chain Turnover: A New Type of Synthetic LethalityNiamh McDermott, Erika S Buechelmaier, Simon N Powell
Nature Reviews. Urology|August 20, 2014
NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancerVictoria Anastasia Belle, Niamh McDermott, Armelle Meunier, et al.
Clinical and Translational Radiation Oncology|April 17, 2018
Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAsNiamh McDermott, Armelle Meunier, Simon Wong, et al.
The Journal of Biological Chemistry|November 28, 2024
β<sub>1</sub>-integrin controls IGF-1R internalization and intracellular signalingNiamh McDermott, Stephen O'Shea, Leonie Rieger, et al.
International Journal of Radiation Biology|December 20, 2013
Isogenic radiation resistant cell lines: development and validation strategiesNiamh McDermott, Armelle Meunier, Thomas H Lynch, et al.
Cancer Treatment Reviews|September 11, 2017
The Notch-3 receptor: A molecular switch to tumorigenesis?Shakeel Inder, Sinead O'Rourke, Niamh McDermott, et al.
Heliyon|July 22, 2016
Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cellsArmelle Meunier, Victoria Anastasia Belle, Niamh McDermott, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The 9-1-1 complex protects ssDNA gaps in BRCA2-deficient cancerHelen E Grimsley, Katherine Courtemanche, Shane Cox, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2024
Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient TumorsJennifer Ma, Rachna Shah, Andrew C Bell, et al.
Pageof 2